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The effect of phytohemagglutinin(PHA)-activated human peripheral mononuclear cell supernatant (AS) on 
collagen production by human libroblasts was examined. The AS inhibited collagen production in a dose- 
and time-dependent manner. Labeling and pulse chase xperiments showed that it did not block collagen 
secretion, but a greater proportion of molecules synthesized in its presence accumulated within the cells. 
Amino acid analysis howed that when labeling was done at 24°C prolyl hydroxylation in fibroblasts ex- 
posed to the AS was reduced to two-thirds of the cultures treated with control supernatant (CS), however 
it was not different at 37°C. These results indicate that the AS inhibits collagen hydroxylation, that the un- 
(under)hydroxylated collagen molecules are degraded at physiological temperature and that suppression of 
collagen hydroxylation may be a mechanism by which the AS inhibits collagen production. 
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1. INTRODUCTION 
Fibroblasts are the major cell type responsible 
for synthesis of matrix components. Peripheral 
blood mononuclear cells activated by a variety of 
substances such as bacterial endotoxins and 
phytohemagglutinin (PHA) elaborate mediators 
that modify the proliferation and synthesis ac- 
tivities of fibroblasts. These substances, which are 
secreted into the culture medium, have been shown 
to be stimulatory as well as inhibitory to fibroblast 
activities [l-8]. A protein which inhibits collagen 
production by fibroblasts has been partially 
characterized and it was shown to have an A4, of 
approx. 55000 [9, lo]. The mechanism by which 
collagen production is inhibited is not known. 
Here we show that supernatants of mononuclear 
cells activated by PHA inhibit prolyl hydroxyla- 
tion; this may be a mechanism by which collagen 
production is affected. 
2. MATERIALS AND METHODS 
Human gingival fibroblasts were used for the ex- 
periments. PHA-activated human peripheral 
blood mononuclear cell supernatant (AS) was 
prepared as in [8]. Briefly, mononuclear cells were 
isolated by sedimentation in Ficoll hypaque (Litton 
Bionetics, Kensington, MD), washed twice with 
Hank’s balanced salt solution, and cultured in 
RPMI-1640 medium at a cell concentration of 2 x 
lo6 cells/ml for 72 h with 15 pg/ml of PHA-P 
(Difco Laboratories, Detroit, MI). For the control 
supernatant (CS) the PHA-P was added at the end 
of incubation. After incubation the media were 
separated and dialyzed vs RPM1 medium prior to 
use. Fibroblasts were treated with 1: 10 dilution of 
AS or CS for 24 h, except when specified other- 
wise, and then labeled with 5 &i/ml of L- 
[3,4-3H]proline and [2-3H]glycine in RPM1 
medium containing 0.2% serum in the presence of 
50pg/ml each of ascorbic acid and fl- 
aminopropionitrile and collagen was quantitated 
by digestion with purified bacterial collagenase 
(Advance Biofactures, Lynnbrook, NY) [l 11. To 
determine the extent of prolyl hydroxylation, 
medium and cell proteins were combined, 
hydrolyzed in 6 M HCI at 108°C for 24 h, radioac- 
tive proline and hydroxyproline were separated us- 
ing a Beckman 120C amino acid analyzer and their 
radioactivity was measured by liquid scintillation 
counting [ 121. For determination of collagen types, 
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procollagens were converted to collagens by hibition of collagen production could be seen as 
limited pepsin digestion, separated on DEAE- early as 6 h after exposure to AS and it reached 
cellulose columns at 15°C and on SDS-slab gels, maximum after 24 h (fig.lB). It was not reversible 
located by fluorography and quantitated by scann- even after 48 h after the removal of AS (not 
ing the fluorograms [12]. shown). 
3. RESULTS AND DISCUSSION 
Incubation with AS resulted in inhibition of col- 
lagen production, which was dose dependent at 
dilutions less than 1 : 50 (fig. 1A). (The results for 
AS and CS were also compared relative to RPM1 
medium alone, which was not exposed to 
mononuclear cells. The CS exhibited some inhibi- 
tion of collagen production relative to the RPM1 
medium and it was dose dependent. Thus it ap- 
pears that mononuclear cells elaborate the 
collagen-inhibitory factor in the absence of PHA 
and that the elaboration is enhanced by the PHA. 
The inhibitory factor was not PHA because addi- 
tion of PHA-P to the fibroblasts had no effect.) 
However, total incorporation remained similar to 
the cells treated with CS; this indicated that the 
production of noncollagenous proteins was not 
significantly affected. The inhibition of collagen is 
not reflected in total incorporation probably 
because of the low proline and glycine content of 
noncollagenous proteins relative to collagen, 
however it is noticeable at 1: 1 dilution when col- 
lagen production is reduced significantly. The in- 
hours 
To determine whether the inhibition is directed 
towards any particular collagen type, the quan- 
tities and proportions of types I, III, and V col- 
lagens in fibroblasts treated with CS and AS were 
compared. From table 1 it can be seen that the 
radioactivity in each collagen type is less in the 
presence of AS but their proportions remained 
identical to the CS-treated cultures, indicating that 
all collagens are affected in a parallel fashion. Our 
results are in contrast to those of Parrott et al. [5] 
who observed that activated mononuclear cell 
supernatants increase fibroblast collagen produc- 
tion, especially type III. 
To understand the mechanism by which AS in- 
hibits collagen production the following ex- 
periments were done. We compared the membrane 
transport of [3H]proline and [3H]glycine in 
fibroblasts treated with either AS or CS, but 
observed no differences (not shown). Next we ex- 
amined whether collagen secretion is inhibited so 
that it accumulates within the cells causing feed- 
back inhibition. Cells were treated for 24 h with 
the supernatants, then labeled for 6 h and the pro- 
portions of collagen in cells and medium were 
determined. Results showed that a greater propor- 
tion of collagen was present in the cells of AS 
treated fibroblasts relative to the CS (54% vs 37%, 
table 2, expt l), indicating that the secretion of col- 
lagen synthesized in the presence of the AS may be 
retarded. To investigate whether the secretion of 
molecules synthesized under normal conditions is 
Table 1 
Effect of mononuclear cell supernatants on collagen 
types made by fibroblasts 
Fig.1. Effect of activated (AS) and control (CS) human 
mononuclear cell supernatants on protein and collagen 
production by human fibroblasts. (A) Effects of 
different dilutions of AS. The results are presented as ‘-70 
relative to the CS for each dilution and they represent 
the mean of triplicates. (O---O) Total incorporation, 
(o--o) collagen. (B) Effect of exposure time on 
collagen production; cells were treated with the 
supernatants at 1: 10 dilution. (O---O) CS, (M) AS. 
Supernatant cpm x 10e3 Percent 
I III v I III v 
Control 302.9 32.1 1.4 90.0 9.5 0.4 
Activated 66.0 6.5 0.4 90.5 8.9 0.5 
Cells were treated with the supernatants at 1: 10 
dilutions for 24 h, and then labeled for 24 h. Collagen 
types were quantitated as described in section 2 
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affected, fibroblasts were labeled for 6 h in the 
absence of AS or CS, then the medium was re- 
placed with fresh medium containing AS or CS 
plus unlabeled proline and glycine. The incubation 
was continued for 3 h and the distribution of col- 
lagen in medium and cells was determined. How- 
ever, no significant differences were observed (expt 
2, table 2). 
The above experiments howed that the AS does 
not totally block collagen secretion, but accumula- 
tion of collagen within the cells indicated that 
molecules made in its presence may be secreted at 
a slower rate. Because unhydroxylated collagen is 
secreted at a slower rate [ 131, we examined whether 
the AS affects collagen hydroxylation. This was 
done as follows: two sets of fibroblast cultures 
were incubated for 24 h with AS or CS. Then one 
set was labeled at 37’C for 24 h, and the other at 
24°C. The prolyl hydroxylation in both cultures 
was then quantitated. At 24°C un(der)hydrox- 
ylated collagen molecules, if made, will remain tri- 
ple helical and will not be degraded [14,15]; thus 
the value for prolyl hydroxylation will be less. First 
we compared the intracellular proteins; however, 
because a majority of collagen was present in the 
medium and hydroxyproline counts remaining in 
the cells at 24°C were very few, media plus cells 
were combined for analysis. The results showed 
that when labeling was done at 37°C no differences 
were present between the AS and CS treated 
cultures (table 3, expt 1). However, at 24’C the 
percent prolyl hydroxylation in the presence of AS 
was reduced to less than two-thirds of the CS 
treated cultures (expts 2 and 3, table 3). 
These results show that hydroxylation of col- 
lagen molecules made in the presence of AS is 
reduced. Steinmann et al. [16] observed that reduc- 
tion of collagen hydroxylation by one-third by 
ascorbic acid deficiency causes a four-fold increase 
in its degradation. Bienkowski et al. [17] showed 
that prevention of prolyl ‘hydroxylation by 
cis-4-hydroxyproline increases intracellular col- 
lagen degradation a-fold, which was shown to oc- 
cur in the lysosomes [ 181. Therefore, collagen 
molecules with reduced prolyl hydroxylation and 
synthesized in the presence of AS are likely to be 
degraded at 37”C, and if so the remaining 
molecules will be normally hydroxylated. In addi- 
tion, the degradation will result in a corresponding 
decrease in collagen production. Accordingly, the 
prolyl hydroxylation at 37°C appears normal 
(table 3), and the reduction in prolyl hydroxyla- 
tion, which is approximately one-third, and the 
decrease in collagen production are comparable 
(cf. table 3 with fig. 1). In similar experiments done 
at 37”C, Jimenez et al. [4] also did not find a 
reduction in prolyl hydroxylation. 
Our observations indicate that suppression of 
collagen hydroxylation may be a mechanism by 
which AS inhibits collagen production by 
fibroblasts. However, how it inhibits prolyl 
hydroxylation and whether the enzyme prolyl 
hydroxylase is affected are not known. Whether 
additional mechanisms uch as reduction of col- 
lagen mRNA levels operate is also not known. 
Table 2 
Effect of mononuclear cell supernatants oncollagen secretion 
No. Supernatant Treatment cpm collagen x 10-3a % collagen in 
Cells Medium Cells Medium 
lb activated - 10.5 f 0.4 9.0 + 0.6 54 46 
control - 9.8 f 0.8 16.7 + 1.5 37 63 
2c none pulse 6.2 f 0.4 - 100 - 
activated chase 2.9 f 0.7 2.0 + 0.3 59 41 
control chase 3.1 f 0.3 1.7 f 0.3 65 35 
a Means f SD of triplicates are presented 
b Fibroblasts were exposed to AS or CS at 1: 10 dilution for 24 h and then labeled 
’ Cells were first labeled for 6 h in the absence of AS or CS, then incubated for 3 h in medium with 
1: 10 diluted AS or CS 
231 
Volume 179, number 2 FEBS LETTERS 
Table 3 
January 1985 
Effect of labeling temperature on prolyl hydroxylation in fibroblasts exposed to mononucler 
supernatantsa 
Expt Supernatant Labeling 
temperature 
(“C) 
cpm x 1O-3 
pro hyp 
% proline 
hydroxyIationb 
1 activated 37 28.5 5.1 15.2 
control 37 27.9 5.0 15.2 
2 activated 24 11.6 1.4 10.7 
control 24 14.2 3.0 17.4 
3 activated 24 14.8 2.3 13.5 
control 24 7.9 2.1 21.0 
a Cells in 75-cm’ flasks were treated with 1: 5 diluted AS or CS for 24 h and then labeled for 
24 h. Cell and medium proteins were combined and subjected to amino acid analysis as 
described in section 3 
b cpm hyp x lOO/(cpm hyp + cpm pro) 
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